Barrington Research upgraded shares of NutriSystem (NASDAQ:NTRI) from a market perform rating to an outperform rating in a report published on Thursday morning, MarketBeat Ratings reports. Barrington Research currently has $44.00 price target on the stock.
“We are upgrading our investment rating to OUTPERFORM with a price target of $44, which assumes a conservative 10x EV/adjusted EBITDA multiple and a 16.5x P/E multiple.”,” the firm’s analyst commented.
Other equities analysts have also recently issued reports about the stock. DA Davidson raised shares of NutriSystem from an underperform rating to a neutral rating and raised their target price for the company from $28.00 to $36.00 in a research note on Thursday. ValuEngine cut shares of NutriSystem from a sell rating to a strong sell rating in a research note on Friday, August 24th. B. Riley raised their target price on shares of NutriSystem from $52.00 to $53.00 and gave the company a buy rating in a research note on Tuesday, July 31st. Zacks Investment Research raised shares of NutriSystem from a hold rating to a buy rating and set a $45.00 target price for the company in a research note on Thursday, August 2nd. Finally, BidaskClub cut shares of NutriSystem from a hold rating to a sell rating in a research note on Saturday, August 18th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $45.57.
Shares of NTRI traded down $1.16 during mid-day trading on Thursday, hitting $37.57. 718,525 shares of the company’s stock were exchanged, compared to its average volume of 846,030. The stock has a market capitalization of $982.25 million, a P/E ratio of 19.17, a P/E/G ratio of 1.62 and a beta of 1.27. NutriSystem has a 52 week low of $26.06 and a 52 week high of $55.10.
NutriSystem (NASDAQ:NTRI) last issued its quarterly earnings results on Tuesday, October 30th. The company reported $0.54 earnings per share for the quarter, hitting the consensus estimate of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 44.33%. The company had revenue of $159.30 million during the quarter, compared to analysts’ expectations of $164.18 million. During the same period last year, the business earned $0.49 EPS. The business’s quarterly revenue was up .8% on a year-over-year basis. Equities research analysts forecast that NutriSystem will post 2.1 EPS for the current year.
NutriSystem declared that its board has authorized a stock repurchase plan on Tuesday, October 30th that permits the company to repurchase $75.00 million in shares. This repurchase authorization permits the company to repurchase up to 7.7% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its shares are undervalued.
The company also recently announced a quarterly dividend, which will be paid on Monday, November 19th. Investors of record on Friday, November 9th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.00 annualized dividend and a dividend yield of 2.66%. NutriSystem’s dividend payout ratio is presently 51.02%.
Large investors have recently added to or reduced their stakes in the stock. Raymond James & Associates boosted its position in NutriSystem by 2.7% during the second quarter. Raymond James & Associates now owns 139,076 shares of the company’s stock worth $5,354,000 after purchasing an additional 3,620 shares during the period. Atria Investments LLC bought a new position in NutriSystem during the second quarter worth $394,000. First Mercantile Trust Co. bought a new position in NutriSystem during the second quarter worth $119,000. Point72 Asset Management L.P. bought a new position in NutriSystem during the second quarter worth $3,238,000. Finally, Aperio Group LLC bought a new position in NutriSystem during the second quarter worth $313,000.
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
See Also: Understanding each part of a balance sheet
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.